Rheumatoid Arthritis Diagnostic Tests Helps In Early Diagnosis Of Rheumatoid Arthritis

 

Rheumatoid Arthritis Diagnostic Tests

There are several different types of rheumatoid arthritis diagnostic tests. Usually, an abnormal CBC test is not a sign of rheumatoid arthritis, as many different conditions can cause the same symptoms. However, a blood test that detects high levels of rheumatoid factor proteins, which are antibodies produced by the body's immune system, can suggest the condition. In fact, high levels of rheumatoid factor proteins in the blood can be a sign of rheumatoid arthritis.

A blood test called CRP (erythrocyte sedimentation rate) can be used to assess inflammation. When a blood test shows high levels of CRP, inflammation is present. However, a high CRP level does not necessarily mean that patient has rheumatoid arthritis. In some cases, an elevated CRP level may be an indication of an infection, rather than rheumatoid arthritis.

According to Coherent Market Insights, The global Rheumatoid Arthritis Diagnostic Tests Market is estimated to account for US$ 3,480.9 Mn in terms of value by the end of 2027

A doctor may use a combination of the above tests to determine the presence of rheumatoid arthritis in a person. If the symptoms persist, a doctor may order a blood test to confirm the diagnosis. Alternatively, a doctor may order imaging tests or blood tests. Symptomatic signs of rheumatoid arthritis may not be apparent during a patient's first visit, as they may develop gradually over time. Treatment options may include pain management, physical therapy, and dietary changes.

Inflammation is one of the hallmarks of rheumatoid arthritis. The erythrocyte sedimentation rate (ESR) test is a nonspecific diagnostic test that measures how quickly red blood cells separate from one another. Inflammation is a hallmark of rheumatoid arthritis, but some healthy individuals also have low levels of this substance.

Imaging tests are another way to diagnose RA. X-rays and ultrasounds can show erosions that indicate joint damage. A thorough RA diagnosis is important because symptoms can manifest before structural damage becomes evident.

MRIs are imaging tests that use a powerful magnetic field to create detailed images of the joints. MRIs can detect inflammation in the synovium, and the membrane lining joints. These are both indicators of RA, and they are recommended for use once or twice a year. MRIs are not widely used to diagnose RA, but they can help a doctor determine if the disease is active. Early diagnosis is vital for reducing symptoms and maximizing quality of life.

The anti-CCP test is also highly specific for RA, but it does not diagnose the disease in 20 percent of cases. The normal range of anti-CCP is 20 ug/ml, and elevated levels suggest that the disease may be present. However, elevated levels can also be due to other causes, such as certain chronic infections, normal aging, transfusions, and certain vaccinations. Moreover, elevated RF levels can persist even after the disease has gone into remission.

The increasing geriatric population will accentuate the demand for Rheumatoid Arthritis Diagnostic Tests. The prevalence of RA is increasing globally, and the percentage of individuals over 65 years old is projected to double in the next two decades. The market for Rheumatoid Arthritis Diagnostic Tests will grow at a CAGR of 8.6% from 2017 to 2026, according to the Annals of the Rheumatic Diseases.